ISRCTN19673867已完成未知
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in Cuba
World Health Organization (WHO) (Switzerland)0 个研究点目标入组 320 人开始时间: 2007年8月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 320
研究概览
简要总结
2013 Results article in https://pubmed.ncbi.nlm.nih.gov/23363495/ results (added 30/09/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Healthy newborns (greater than 2.5 kg, apgar score greater than 9 at five minutes)
- •2. Living within the catchment area of the participating polyclinics
- •3. Newborns delivered by caesarian section
排除标准
- •1. Newborns requiring hospitalisation (except if in hospital because of maternal admission)
- •2. Birth weight below 2.5 kg
- •3. Apgar score less than 9
- •4. Residence outside the catchment area, or families expecting to move away during the study period
- •5. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will also render the newborn ineligible for the study
研究者
相似试验
已完成
不适用
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in the Sultanate of OmaPoliomyelitis vaccinationInfections and InfestationsPoliomyelitisISRCTN17418767World Health Organization (WHO) (Switzerland)400
已完成
4 期
Comparison of immune response of fractional doses, administered intradermally vs. full doses administered intramuscularly of inactivated poliovirus vaccine (IPV) in male adults in Camaguey, Cuba.PoliomyelitisInfection - Other infectious diseasesPublic Health - EpidemiologyACTRN12615000305527World Health Organization600
已完成
2 期
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly SubjectsOrthomyxoviridae InfectionMyxovirus InfectionInfluenzaNCT00388583Sanofi817
已完成
不适用
ID Administration of fIPV Using Intradermal Adapters vs. BCG SyringeIPVNCT02769923Aga Khan University450
已完成
3 期
Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 MonthsPoliomyelitisNCT03671616Statens Serum Institut666